Darling Helen 4
4 · Teladoc Health, Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
Darling Helen
Director
Transactions
- Exercise/Conversion
Common Stock
2020-06-11$30.50/sh+7,689$234,515→ 8,607 total - Sale
Common Stock
2020-06-11$180.00/sh−7,689$1,384,020→ 918 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-11−7,689→ 0 totalExercise: $30.50Exp: 2027-05-25→ Common Stock (7,689 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.
- [F2]The option vested in full on May 25, 2018.